Further, the Wnt/β-catenin signaling pathway, which is active in ovarian cancer and tumor progression, may regulate the expression of IDO, a known immunosuppressant, by tumor-associated myeloid cells through an LEF-1-associated mechanism [70]. This evidence concerns the gene LEF1 and neoplasm.